Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 AUD | -8.33% | +10.00% | +10.00% |
Mar. 08 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
Feb. 28 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Sales 2022 | 3.4K 2.24K | Sales 2023 | 42.02K 27.65K | Capitalization | 23.4M 15.4M |
---|---|---|---|---|---|
Net income 2022 | -1M -658K | Net income 2023 | -2M -1.32M | EV / Sales 2022 | 1,775 x |
Net cash position 2022 | 4.24M 2.79M | Net cash position 2023 | 4.11M 2.71M | EV / Sales 2023 | 459 x |
P/E ratio 2022 |
-3.58
x | P/E ratio 2023 |
-9.38
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 59.45% |
1 day | -8.33% | ||
1 week | +10.00% | ||
Current month | +10.00% | ||
1 month | +10.00% | ||
3 months | +10.00% | ||
6 months | -8.33% | ||
Current year | +10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Daya Uka
DFI | Director of Finance/CFO | - | 15-12-31 |
James Mckenna
CTO | Chief Tech/Sci/R&D Officer | - | 23-06-18 |
Chief Operating Officer | - | 21-12-12 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hainsworth
CHM | Chairman | 50 | 22-10-30 |
Bradley Dilkes
BRD | Director/Board Member | 39 | 22-10-30 |
Bradley Latham
BRD | Director/Board Member | 62 | 23-07-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.011 | -8.33% | 555 452 |
24-05-02 | 0.012 | +20.00% | 4,094,940 |
24-05-01 | 0.01 | 0.00% | 460,596 |
24-04-30 | 0.01 | -9.09% | 1,001,759 |
24-04-29 | 0.011 | +10.00% | 1,115,272 |
Delayed Quote Australian S.E., May 03, 2024 at 12:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+10.00% | 13.25M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.35% | 23.07B | |
-12.60% | 22.23B | |
-6.31% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- 1AI Stock